Preliminary experiments have shown that GranaGard can reduce the activity of Complex I in the respiratory chain of the mitochondria. While this can somewhat reduce the production of ATP, it can concomitantly inhibit the formation of free radicals, thereby reducing the toxicity of respiration to cells.
Article, , Ongoing research, 0
Granalix is conducting a survey among people taking GranaGard for several months. No adverse effect have been reported....